ID: ALA3357627

Max Phase: Preclinical

Molecular Formula: C20H21BrN4O4

Molecular Weight: 461.32

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  O=C(NC[C@@H]1CC(Br)=NO1)[C@@H]1CCCN1C(=O)OCc1ccnc2ccccc12

Standard InChI:  InChI=1S/C20H21BrN4O4/c21-18-10-14(29-24-18)11-23-19(26)17-6-3-9-25(17)20(27)28-12-13-7-8-22-16-5-2-1-4-15(13)16/h1-2,4-5,7-8,14,17H,3,6,9-12H2,(H,23,26)/t14-,17-/m0/s1

Standard InChI Key:  ZYCAQSJUEDRXEL-YOEHRIQHSA-N

Associated Targets(Human)

Protein-glutamine gamma-glutamyltransferase K 164 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Protein-glutamine gamma-glutamyltransferase 1221 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 461.32Molecular Weight (Monoisotopic): 460.0746AlogP: 2.95#Rotatable Bonds: 5
Polar Surface Area: 93.12Molecular Species: NEUTRALHBA: 6HBD: 1
#RO5 Violations: 0HBA (Lipinski): 8HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 4.37CX LogP: 2.11CX LogD: 2.10
Aromatic Rings: 2Heavy Atoms: 29QED Weighted: 0.74Np Likeness Score: -1.06

References

1. Klöck C, Herrera Z, Albertelli M, Khosla C..  (2014)  Discovery of potent and specific dihydroisoxazole inhibitors of human transglutaminase 2.,  57  (21): [PMID:25333388] [10.1021/jm501145a]

Source